Imatinib Mesylate
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease (NCT00702689) | National Cancer Institute (NCI) | 2008-12-15 |
Track Imatinib Mesylate automatically
Every clearance here is in the API, with alerts when new ones post.